Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate the efficacy and safety of Pitavastatin versus Pitavastatin/Fenofibrate in complex-dyslipidemia patients.
Full description
The purpose of this study is to demonstrate the efficacy of the Pitavastatin/Fenofibrate in complex-dyslipidemia patients by the reduction of non-HDL-Cholesterol levels compared with Pitavastatin.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
High risk patient to Coronary Heart Disease
At visit 1(Screening)
LDL-C<100mg/dL and 150mg/dL≤TG<500mg/dL after 4 weeks of Pitavastatin 2mg monotherapy
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
347 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal